Shijiazhuang Yiling Pharmaceutical Co., Ltd. Stock price

Equities

002603

CNE1000015S0

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-02-22 pm EST 5-day change 1st Jan Change
21.3 CNY -0.05% Intraday chart for Shijiazhuang Yiling Pharmaceutical Co., Ltd. +2.65% -7.67%
Sales 2023 * 11.2B 1.56B Sales 2024 * 12.97B 1.8B Capitalization 35.59B 4.95B
Net income 2023 * 2.15B 299M Net income 2024 * 2.53B 352M EV / Sales 2023 * 3.07 x
Net cash position 2023 * 1.2B 167M Net cash position 2024 * 2.35B 326M EV / Sales 2024 * 2.56 x
P/E ratio 2023 *
16.5 x
P/E ratio 2024 *
14 x
Employees 15,074
Yield 2023 *
2.24%
Yield 2024 *
2.35%
Free-Float 41.69%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.05%
1 week+2.65%
Current month+8.18%
1 month-1.48%
3 months-6.95%
6 months-7.39%
Current year-7.67%
More quotes
1 week
20.63
Extreme 20.63
21.50
1 month
17.80
Extreme 17.8
22.46
Current year
17.80
Extreme 17.8
24.47
1 year
17.80
Extreme 17.8
33.29
3 years
14.89
Extreme 14.8929
53.96
5 years
7.15
Extreme 7.15
53.96
10 years
7.08
Extreme 7.0786
53.96
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 04-12-31
Director of Finance/CFO 51 96-12-31
Director/Board Member 54 15-03-15
Members of the board TitleAgeSince
Founder 75 01-08-27
Chief Executive Officer 49 04-12-31
Chairman 54 10-08-30
More insiders
Date Price Change Volume
24-02-22 21.3 -0.05% 12 618 740
24-02-22 21.31 +0.42% 12,421,850
24-02-21 21.22 -0.42% 14,927,190
24-02-20 21.31 +2.30% 16,353,380

End-of-day quote Shenzhen S.E., February 22, 2024

More quotes
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company mainly provides cardiovascular and cerebrovascular drugs and anti-cold drugs. The Company also provides food and beverage products. The Company distributes its products within domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
21.3 CNY
Average target price
27.02 CNY
Spread / Average Target
+26.87%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd. - Shenzhen S.E.
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer